ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Dr. Steven Nissen: There is a consistent pattern of failure in medical devices

Dr. Steven Nissen: There is a consistent pattern of failure in medical devices

March 28, 2012 3:53 pm by | 0 Comments

The Cleveland Clinic‘s Dr. Steven Nissen, the top cardiologist at the top-rated cardiology hospital in the U.S., recently weighed in on the controversy over medical device failures.“I think people make ... Read more

Cleveland Clinic cardiologists: You can die from a broken heart

Cleveland Clinic cardiologists: You can die from a broken heart

January 20, 2012 11:03 am by | 0 Comments

Intense grief, such as what’s felt at the death of a spouse, can increase a person’s risk of developing cardiac problems that lead to death, according to a new article ... Read more


Ex-Cleveland Clinic colleagues Topol, Nissen at odds on personalized medicine

Ex-Cleveland Clinic colleagues Topol, Nissen at odds on personalized medicine

December 28, 2011 5:05 pm by | 0 Comments

Two of the Cleveland Clinic‘s greatest doctors ever, Eric Topol and Steven Nissen, have carved out contrasting views on one of the hottest topics in healthcare: personalized medicine.The preeminent cardiologists’ ... Read more

4 takeaways (and 2 questions) from Cleveland Clinic Innovation Summit

4 takeaways (and 2 questions) from Cleveland Clinic Innovation Summit

October 6, 2011 12:44 pm by | 2 Comments

Cleveland Clinic’s 2012 Medical Innovation Summit, this year dedicated to cardiovascular technology, has come and gone.But it’s worth taking a look back at a few observations and insights gleaned from ... Read more

Cleveland Clinic’s Steven Nissen: The need for head-to-head drug trials

Cleveland Clinic’s Steven Nissen: The need for head-to-head drug trials

October 5, 2011 7:36 am by | 2 Comments

Dr. Steven Nissen, chair of Cleveland Clinic’s cardiovascular medicine department, talks about why head-to-head clinical trials of competing drugs and devices would benefit patients.“In medicine, we have many alternative therapies ... Read more

Steven Nissen for FDA deputy commissioner? The Twitterati say no.

Steven Nissen for FDA deputy commissioner? The Twitterati say no.

January 7, 2011 11:00 am by | 1 Comments

On Thursday, MedCity News' Brandon Glenn floated the idea of Cleveland Clinic's Steven Nissen replacing US Food & Drug Administration Deputy Commissioner Joshua Sharfstein, who left to head Maryland’s ... Read more

Sharfstein’s FDA replacement: Why not Cleveland Clinic’s Steven Nissen?

Sharfstein’s FDA replacement: Why not Cleveland Clinic’s Steven Nissen?

January 6, 2011 12:08 pm by | 0 Comments

FDA Deputy Commissioner Joshua Sharfstein's departure may be an olive branch to newly empowered Congressional Republicans. Replacing him with Cleveland Clinic's Steven Nissen would signal the exact opposite from President ... Read more


Cerenis Therapeutics adds $13.9M for plaque-reversing heart drug

Cerenis Therapeutics adds $13.9M for plaque-reversing heart drug

October 22, 2010 7:07 pm by | 0 Comments

Ann Arbor, Michigan, biopharmaceutical company Cerenis Therapeutics added $13.9 million to a July investment round that it will use to continue clinical trials of a drug to treat heart disease. ... Read more

Nissen calls FDA’s Avandia decision ‘reasonable’ (Morning Read)

Nissen calls FDA’s Avandia decision ‘reasonable’ (Morning Read)

September 24, 2010 8:56 am by | 0 Comments

What does Cleveland Clinic cardiologist (and Avandia whistleblower) Steven Nissen have to say about Thursday's Food and Drug Administration decision to allow diabetes drug Avandia to stay on the market ... Read more

What will Novartis’ multiple sclerosis pill cost? (Morning Read)

What will Novartis’ multiple sclerosis pill cost? (Morning Read)

September 23, 2010 8:43 am by | 0 Comments

Swiss drugmaker Novartis just got Food and Drug Administration approval to sell the first pill that can slow the progression of multiple sclerosis. Gilenya will go head-to-head with injectable medicines, ... Read more

Avandia: the beginning of the end?

Avandia: the beginning of the end?

September 6, 2010 1:37 pm by | 0 Comments

The British Medical Journal today raised more questions about whether diabetes drug Avandia should ever have been approved for patients in the United States and Europe, and whether the ... Read more

Steven Nissen takes developer’s side of cholesterol drug debate

Steven Nissen takes developer’s side of cholesterol drug debate

May 27, 2010 1:01 pm by | 1 Comments

Dr. Steven Nissen, the Cleveland Clinic’s high-profile cardiovascular medicine chair, is staking his reputation as a drug-safety advocate on a shortened regulatory pathway for a cholesterol-fighting drug made by a ... Read more

Night Read (Ohio): Christ Hospital Mount Auburn plans expansion

Night Read (Ohio): Christ Hospital Mount Auburn plans expansion

February 22, 2010 7:57 pm by | 0 Comments

Two years after emerging as an independent with aspirations to become one of the nation's top hospitals, Christ Hospital in Mount Auburn hopes to spend hundreds of millions of dollars ... Read more

Cleveland Clinic enlightens debate on health care reform — MedCity Morning Read, June 22, 2009

Cleveland Clinic enlightens debate on health care reform — MedCity Morning Read, June 22, 2009

June 22, 2009 7:31 am by | 0 Comments

CNN's State of the Union host and chief national correspondent John King went inside the Cleveland Clinic for online and broadcast reports on the next generation of health care in ... Read more

Steven Nissen: Blockbuster drugs are dead. Embrace ‘innovative’ regulation

Steven Nissen: Blockbuster drugs are dead. Embrace ‘innovative’ regulation

June 4, 2009 2:31 pm by | 1 Comments

Nissen is a bit fire-and-brimstone when speaking to the public about the U.S. Food and Drug Administration. But Thursday afternoon, he was standing in front of fellow cardiologists -- as ... Read more